More Substance Use News and Updates
News
07/08/2024
A pharmacokinetics study of AD04, a potential treatment for AUD, is designed to meet an FDA requirement for an upcoming phase 3 trial and is expected to last 6 months.
A pharmacokinetics study of AD04, a potential treatment for AUD, is designed to meet an FDA requirement for an upcoming phase 3 trial and is expected to last 6 months.
A pharmacokinetics study of...
07/08/2024
Psych Congress Network
News
05/22/2024
Evidence is increasingly finding adolescence to be a critical period for the development of cannabis use disorder, according to a commentary article in the American Journal of Psychiatry.
Evidence is increasingly finding adolescence to be a critical period for the development of cannabis use disorder, according to a commentary article in the American Journal of Psychiatry.
Evidence is increasingly finding...
05/22/2024
Psych Congress Network
News
05/15/2024
Though the number of buprenorphine prescribers increased following the elimination of the X waiver in January 2023, the total number of patients using the medication to manage opioid use disorder (OUD) “changed little.”
Though the number of buprenorphine prescribers increased following the elimination of the X waiver in January 2023, the total number of patients using the medication to manage opioid use disorder (OUD) “changed little.”
Though the number of...
05/15/2024
Psych Congress Network
News
04/18/2024
Insomnia symptoms, even if mild, were found to be associated with increased drinking over time, according to findings from the “first study to examine if objective circadian measures can predict future alcohol use in adults.”
Insomnia symptoms, even if mild, were found to be associated with increased drinking over time, according to findings from the “first study to examine if objective circadian measures can predict future alcohol use in adults.”
Insomnia symptoms, even if mild,...
04/18/2024
Psych Congress Network
News
04/09/2024
Harm reduction services for people with SUD demonstrate efficacy, but they continue to encounter social stigma and barriers, according to a poster presentation at the RX and Illicit Drug Summit.
Harm reduction services for people with SUD demonstrate efficacy, but they continue to encounter social stigma and barriers, according to a poster presentation at the RX and Illicit Drug Summit.
Harm reduction services for...
04/09/2024
Psychiatry & Behavioral Health
Q&As
03/22/2024
Featuring Brittany Badinger, FNP-C, CARN-AP
Featuring Brittany Badinger, FNP-C, C...
Brittany Badinger, FNP-C, CARN-AP, provides practical tips on how mental health clinicians can be more aware of comorbid substance use disorders when assessing and treating patients.
Brittany Badinger, FNP-C, CARN-AP, provides practical tips on how mental health clinicians can be more aware of comorbid substance use disorders when assessing and treating patients.
Brittany Badinger, FNP-C,...
03/22/2024
Psych Congress Network
News
06/13/2023
In smokers with MDD, varenicline improved 27-week smoking cessation compared with placebo, according to recent study results.
In smokers with MDD, varenicline improved 27-week smoking cessation compared with placebo, according to recent study results.
In smokers with MDD, varenicline...
06/13/2023
Psych Congress Network
Videos
03/23/2023
In this clip from Psych Congress 2022 in Dr Arwen Podesta, discusses how to treat comorbid disorders with SUDs and what clinicians should prioritize.
In this clip from Psych Congress 2022 in Dr Arwen Podesta, discusses how to treat comorbid disorders with SUDs and what clinicians should prioritize.
In this clip from Psych Congress...
03/23/2023
Psych Congress Network
News
03/16/2023
Study results were recently published in JAMA Network Open.
Study results were recently published in JAMA Network Open.
Study results were recently...
03/16/2023
Psych Congress Network
Videos
03/15/2023
In this clip from Psych Congress 2022 in New Orleans, Louisiana, Dr Arwen Podesta, board-certified adult psychiatrist at Podesta Psychiatry LLC, discusses 2022 trends in substance use.
In this clip from Psych Congress 2022 in New Orleans, Louisiana, Dr Arwen Podesta, board-certified adult psychiatrist at Podesta Psychiatry LLC, discusses 2022 trends in substance use.
In this clip from Psych Congress...
03/15/2023
Psych Congress Network
